EA201591742A1 - Способ улучшения диагностики заболеваний с использованием измеряемых аналитов - Google Patents

Способ улучшения диагностики заболеваний с использованием измеряемых аналитов

Info

Publication number
EA201591742A1
EA201591742A1 EA201591742A EA201591742A EA201591742A1 EA 201591742 A1 EA201591742 A1 EA 201591742A1 EA 201591742 A EA201591742 A EA 201591742A EA 201591742 A EA201591742 A EA 201591742A EA 201591742 A1 EA201591742 A1 EA 201591742A1
Authority
EA
Eurasian Patent Office
Prior art keywords
improving diagnostic
measured analytes
diseases
diagnostic diseases
analytes
Prior art date
Application number
EA201591742A
Other languages
English (en)
Inventor
Галина Красик
Мохсен Марефат
Кит Лингенфелтер
Original Assignee
Отрейсиз Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Отрейсиз Инк. filed Critical Отрейсиз Инк.
Publication of EA201591742A1 publication Critical patent/EA201591742A1/ru

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N20/00—Machine learning
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Data Mining & Analysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Theoretical Computer Science (AREA)
  • Databases & Information Systems (AREA)
  • Software Systems (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Evolutionary Computation (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Artificial Intelligence (AREA)
  • Primary Health Care (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Bioethics (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Computing Systems (AREA)
  • Chemical & Material Sciences (AREA)
  • Mathematical Physics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

Обеспечены способы улучшения клинических диагностических тестов, а также ассоциированные диагностические технологии.
EA201591742A 2013-03-14 2014-03-13 Способ улучшения диагностики заболеваний с использованием измеряемых аналитов EA201591742A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361851867P 2013-03-14 2013-03-14
PCT/US2014/000041 WO2014158287A2 (en) 2013-03-14 2014-03-13 A method for improving disease diagnosis using measured analytes

Publications (1)

Publication Number Publication Date
EA201591742A1 true EA201591742A1 (ru) 2016-09-30

Family

ID=51625585

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201591742A EA201591742A1 (ru) 2013-03-14 2014-03-13 Способ улучшения диагностики заболеваний с использованием измеряемых аналитов

Country Status (9)

Country Link
US (3) US11699527B2 (ru)
EP (2) EP2971054A4 (ru)
JP (4) JP6554087B2 (ru)
CN (2) CN105209631A (ru)
CA (1) CA2941554A1 (ru)
EA (1) EA201591742A1 (ru)
HK (1) HK1216765A1 (ru)
IL (2) IL241327B (ru)
WO (1) WO2014158287A2 (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2971054A4 (en) 2013-03-14 2017-04-12 Otraces Inc. A method for improving disease diagnosis using measured analytes
JP6625840B2 (ja) * 2015-07-14 2019-12-25 株式会社スタージェン 健康管理支援装置、健康管理支援システム及び健康管理支援方法
JP6952056B2 (ja) * 2016-01-22 2021-10-20 オートレイシーズ, インク.Otraces, Inc. 疾患診断を改善するシステム及び方法
US20190189248A1 (en) * 2016-05-19 2019-06-20 Koninklijke Philips N.V. Methods, systems and apparatus for subpopulation detection from biological data based on an inconsistency measure
CN106339433B (zh) * 2016-08-18 2021-08-24 冯连元 一种基于数据中有关群体数据与个体数据交互比较平台的方法及装置
CN111263965A (zh) * 2017-08-09 2020-06-09 欧特雷瑟斯有限公司 利用测量分析物改善疾病诊断的系统和方法
KR102249986B1 (ko) * 2019-02-12 2021-05-10 주식회사 스마일랩 자가진단기기의 결과를 분석하는 방법 및 장치
JP2022541689A (ja) * 2019-07-13 2022-09-26 オートレイシーズ，インク． 腫瘍微小環境活性蛋白質を用いる種々の疾患の診断の改善
CN112394177B (zh) * 2020-10-30 2022-07-01 上海交通大学 ApoF蛋白在制备或筛选精神分裂症诊断产品中的用途

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60209177A (ja) 1984-04-02 1985-10-21 Chugai Pharmaceut Co Ltd 自動分析装置
CN1194045A (zh) * 1995-07-25 1998-09-23 好乐思治疗公司 计算机辅助疾病诊断方法
US6628809B1 (en) * 1999-10-08 2003-09-30 Lumidigm, Inc. Apparatus and method for identification of individuals by near-infrared spectrum
US6058322A (en) 1997-07-25 2000-05-02 Arch Development Corporation Methods for improving the accuracy in differential diagnosis on radiologic examinations
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
US20030032017A1 (en) * 2001-08-03 2003-02-13 Large Scale Proteomics, Corp. Quantification of low molecular weight and low abundance proteins using high resolution two-dimensional electrophoresis and mass spectrometry
US7604956B2 (en) * 2004-03-01 2009-10-20 Biotraces, Inc. Supersensitive immunoassays
US20080133141A1 (en) 2005-12-22 2008-06-05 Frost Stephen J Weighted Scoring Methods and Use Thereof in Screening
JP2010506588A (ja) 2006-10-17 2010-03-04 シナージェンズ バイオサイエンス リミティド 肺の機能と障害の評価のための方法と組成物
SE532103C2 (sv) 2006-12-12 2009-10-27 Knut Johansen Metod för att bestämma hälsostatus från analyter i vätskeprover
US8431011B2 (en) * 2008-01-31 2013-04-30 Abbott Diabetes Care Inc. Method for automatically and rapidly distinguishing between control and sample solutions in a biosensor strip
US8032308B2 (en) 2008-03-13 2011-10-04 Siemens Medical Solutions Usa, Inc. Modeling lung cancer survival probability after or side-effects from therapy
EP2124060A1 (en) * 2008-05-23 2009-11-25 ETH Zurich Method for high throughput peptide/protein assay generation and assays generated therewith
US20110265197A1 (en) 2008-07-16 2011-10-27 Dana-Farber Cancer Institute, Inc. Signatures and PCDeterminants Associated with Prostate Cancer and Methods of Use Thereof
US20110118141A1 (en) * 2008-07-22 2011-05-19 Siemens Healthcare Diagnostics Inc. Disease Specific Diagnostic Aid
US20120022793A1 (en) 2009-01-19 2012-01-26 Miraculins, Inc. Biomarkers for the diagnosis of prostate cancer in a non-hypertensive population
EP2488666A4 (en) 2009-10-13 2013-05-29 Purdue Research Foundation BIOMARKERS AND METHODS OF IDENTIFICATION FOR EARLY DETECTION AND PREDICTION OF BREAST CANCER RECOVERY USING NMR (NUCLEAR MAGNETIC RESONANCE)
US20120315641A1 (en) 2010-01-08 2012-12-13 The Regents Of The University Of California Protein Markers for Lung Cancer Detection and Methods of Using Thereof
ES2665910T3 (es) 2010-09-21 2018-04-30 Proteomics International Pty Ltd Biomarcadores relacionados con nefropatía diabética
EP2434285A1 (en) 2010-09-22 2012-03-28 IMBA-Institut für Molekulare Biotechnologie GmbH Breast cancer diagnostics
IL278227B (en) 2011-04-29 2022-07-01 Cancer Prevention & Cure Ltd Data classification systems for identifying biomarkers and diagnosing diseases
WO2013036754A2 (en) * 2011-09-09 2013-03-14 The Wistar Institute Of Anatomy And Biology Methods and compositions for diagnosis of ovarian cancer
EP3907506A1 (en) * 2012-03-12 2021-11-10 The Board of Trustees of the University of Illinois Optical analyte detection systems with magnetic enhancement and methods of their use
US20140194304A1 (en) * 2013-01-08 2014-07-10 Battelle Memorial Institute Process for ultra-sensitive quantification of target analytes in complex biological systems
EP2971054A4 (en) 2013-03-14 2017-04-12 Otraces Inc. A method for improving disease diagnosis using measured analytes
US20160019337A1 (en) 2013-03-15 2016-01-21 Htg Molecular Diagnostics, Inc. Subtyping lung cancers
KR102471057B1 (ko) 2014-09-16 2022-11-28 리제너론 파아마슈티컬스, 인크. 전이성 결장직장암의 항-혈관신생 치료요법에 관한 예측 및 예후 바이오마커
JP2018507181A (ja) 2015-01-16 2018-03-15 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー Ｖｅｇｆ変異体ポリペプチド組成物
JP6952056B2 (ja) 2016-01-22 2021-10-20 オートレイシーズ, インク.Otraces, Inc. 疾患診断を改善するシステム及び方法

Also Published As

Publication number Publication date
IL241327A0 (en) 2015-11-30
JP2022020738A (ja) 2022-02-01
EP2971054A2 (en) 2016-01-20
US20230274838A1 (en) 2023-08-31
JP2023156388A (ja) 2023-10-24
WO2014158287A3 (en) 2014-11-27
EP3734609A1 (en) 2020-11-04
IL241327B (en) 2022-02-01
CN105209631A (zh) 2015-12-30
JP2019145127A (ja) 2019-08-29
JP6554087B2 (ja) 2019-07-31
JP7326402B2 (ja) 2023-08-15
JP2016512354A (ja) 2016-04-25
US20160034651A1 (en) 2016-02-04
CN110289092A (zh) 2019-09-27
WO2014158287A2 (en) 2014-10-02
US20170372023A1 (en) 2017-12-28
HK1216765A1 (zh) 2016-12-02
CA2941554A1 (en) 2014-10-02
IL289699A (en) 2022-03-01
US11699527B2 (en) 2023-07-11
EP2971054A4 (en) 2017-04-12

Similar Documents

Publication Publication Date Title
EA201591742A1 (ru) Способ улучшения диагностики заболеваний с использованием измеряемых аналитов
CY1120390T1 (el) Συνθεση και μεθοδος για διαγνωση και θεραπεια ασθενειων που σχετιζονται με εκφυλισμο νευριτων
EA201890013A1 (ru) Способы получения tcr гамма дельтат-клеток
EA201491811A1 (ru) АНТИ-LgR5 АНТИТЕЛА И ИММУНОКОНЪЮГАТЫ
EA201590027A1 (ru) Способы детекции заболеваний или состояний
UY34697A (es) Métodos para preparar análogos de nucleótidos
MX2019005748A (es) Biomarcadores relacionados a la funcion renal y metodos para usar los mismos.
UY34602A (es) ?Derivados de bencimidazolil- e imidazopiridinil-metilamina?
MA34091B1 (fr) Anticorps anti-cd40
UY34824A (es) Nucleósidos de espirooxetano de uracilo
MX2021008755A (es) Un anticuerpo anti-tau para usarse al tratar una tauopatia.
UY34885A (es) Proteínas de unión anti-mesotelina
BR112014031335A2 (pt) bloco de diagnóstico transacional
UY34472A (es) Derivados modificados de 4-fenil-piridina
EA201491947A1 (ru) Антитела и иммуноконъюгаты к ly6e и способы применения
UY34586A (es) Nuevas 5,8-dihidro-6h-pirazolo[3,4-h]quinazolinas como inhibidores de igf-1r/ir
UY33931A (es) Agentes de union biespecificos
UY34097A (es) Alineación de anticoagulante de cebado para extracción de sangre.
UY34473A (es) Ensayo de alto rendimiento de polimorfismo de nucleótido simple
UY33976A (es) Derivados de pirazolo-pirimidina.
EA201990720A1 (ru) Способы детекции нейтрализующих антител к лептину
EA201401201A1 (ru) Способ
DK2972368T3 (da) Lymfocytbiomarkører til at bestemme det kliniske respons på celleterapi
EA201490823A1 (ru) Агенты, реверсирующие действие антикоагулянтов
TR201910413T4 (tr) Benralizumab kullanarak astım semptomlarının iyileştirilmesine yönelik yöntemler.